Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,712,640
+$6,562 QoQ
Shares Held
7,491
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,113
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GRANDFIELD & DODD, LLC holds $118,444,709 across 12 Drug Manufacturers - General names. AMGN ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,768 | $27,115,868 | |
| 2 | NVS |
Novartis AG
|
153,436 | $24,046,489 | |
| 3 | MRK |
Merck & Co., Inc.
|
171,554 | $22,044,689 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
154,287 | $19,492,619 | |
| 5 | SNY |
Sanofi
|
384,643 | $16,408,870 | |
| 6 | AMGN |
Amgen Inc
This page
|
7,491 | $2,712,640 | |
| 7 | LLY |
ELI LILLY & Co
|
2,035 | $2,440,840 | |
| 8 | ABBV |
AbbVie Inc.
|
5,744 | $1,445,420 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,712,640 | 7,491 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,706,078 | 7,691 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,676,086 | 8,176 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,307,267 | 8,176 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,282,820 | 8,176 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,498,007 | 8,018 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,089,811 | 8,018 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,672,087 | 8,293 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,755,184 | 8,818 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,507,133 | 8,818 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,538,320 | 8,813 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,497,586 | 9,293 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,085,433 | 9,393 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,511,540 | 10,389 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2,526,334 | 9,619 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,181,421 | 9,678 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,525,210 | 10,379 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,548,057 | 10,537 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $2,471,745 | 10,987 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,560,943 | 12,043 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $3,220,425 | 13,212 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $3,372,121 | 13,553 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $3,155,652 | 13,725 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $3,713,277 | 14,610 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,615,262 | 15,328 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $3,975,535 | 19,610 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||